Table 2. Sensitivity and Specificity for CAD and MACE.

Interpretation approach	CAD				MACE
	ROC	Sensitivity (%)	Specificity (%)		ROC	Sensitivity (%)	Specificity (%)
MRISQ	0.75	55	89		0.54	38	84
DICE-MRISQ	0.91	100	72		0.75	79	71
BIAS-MRISQ	0.73	67	80		0.78	71	84
MRIQL	0.75	67	80		0.64	50	78
DICE-MRIQL	0.7	78	63		0.68	71	65
BIAS-MRIQL	0.73	67	80		0.78	71	84
SPECT	0.72	55	85		0.63	38	84
DICE-SPECT	0.76	66	85		0.78	70	85
BIAS-SPECT	0.68	55	78		0.82	80	83

Where CAD is coronary artery disease and MACE is major adverse cardiovascular event. CAD, coronary artery disease; MACE, major adverse cardiovascular events; ROC, receiver operator characteristic; DICE, decisions informed by combining entities; MRI, magnetic resonance imaging; MRI_QL, MRI qualitative perfusion assessment; MRI_SQ, MRI semi-quantitative perfusion assessment; SPECT, single photon emission computed tomography; DICE, decisions informed by combining entities; BIAS, bio-informatics assessment schema.